David Benson, Chief Executive Officer GO2 for Lung Cancer shared a post on LinkedIn by GO2 for Lung Cancer, adding:
“I’m incredibly honored to join GO2 for Lung Cancer as its next CEO.
The burden of lung cancer remains unacceptably high. It is still the leading cause of cancer death, and every year nearly 230,000 people in the United States are diagnosed with this disease.
Yet, at the very same time, we are witnessing extraordinary breakthroughs in early detection, precision medicine, targeted therapies, and research that are transforming what’s possible for patients and families.
Real progress is creating real hope.
That’s what excites me most about joining GO2.
I’m grateful to the Board for the opportunity to lead this extraordinary organization and build on the incredible work already underway.
To everyone who has shaped GO2 into the organization it is today, thank you. Your passion, leadership, and commitment have created real progress and real hope for patients and families.
And to everyone who believes we can change the future of lung cancer, I invite you to join us. Together, we can accelerate progress, inspire hope, and ensure that no one faces lung cancer alone.
I’m excited to get started.”
Quoting GO2 for Lung Cancer on LinkedIn:
“Today, we are pleased to welcome David Benson as the new Chief Executive Officer of GO2 for Lung Cancer.
David brings nearly 3 decades of nonprofit leadership experience and a deep commitment to improving the lives of people affected by cancer. Throughout his career, he has built strong partnerships, advanced research and advocacy, expanded patient support, and led organizations through periods of growth and transformation.
‘I was drawn to GO2 because of its extraordinary impact and unwavering commitment to improving the lives of people affected by lung cancer,’
David said.
‘I look forward to building on that strong foundation as we continue expanding our reach and ensuring every person affected by lung cancer has the support and resources they need.’
As we welcome David, we remain focused on the work that drives us every day: advancing research, increasing access to screening and high-quality care, advocating for policies that improve outcomes, and ensuring no one faces lung cancer alone.
Please join us in welcoming David to the GO2 community.
Read the full announcement.”
Other OncoDaily articles about GO2 for Lung Cancer.